← Back to Search

Biological

Platelet-rich plasma (PRP) for Wrist Injuries (TFCC Trial)

N/A
Waitlist Available
Led By John C Dunn
Research Sponsored by William Beaumont Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-injection, 2 weeks, 3 months, 6 months, 12 months

Summary

This trial is testing PRP therapy, which uses a patient's own blood to create a healing injection, on patients with wrist injuries called TFCC tears. The goal is to see if PRP can help these injuries heal faster and reduce pain. Platelet-rich plasma (PRP) is a recently developed technique that uses a concentrated portion of a patient's own blood to try to improve and accelerate the healing of various tissues.

Eligible Conditions
  • Wrist Injuries
  • Platelet Rich Plasma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-injection, 2 weeks, 3 months, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-injection, 2 weeks, 3 months, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Disability of the Army Shoulder Hand (DASH)
Secondary study objectives
Mayo Wrist Score (Mayo)
Michigan Hand Outcome Questionnaire (MHOQ
Pain Anxiety Symptom Scale (PASS)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental - PRP injectionExperimental Treatment1 Intervention
2cc of PRP is injected into the ulnocarpal joint
Group II: control - Saline injectionPlacebo Group1 Intervention
2cc of 0.9% sterile saline is injected into the ulnocarpal joint
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Platelet-rich plasma (PRP)
2009
Completed Early Phase 1
~10

Find a Location

Who is running the clinical trial?

William Beaumont Army Medical CenterLead Sponsor
16 Previous Clinical Trials
2,304 Total Patients Enrolled
John C DunnPrincipal InvestigatorWBAMC Staff Hand Surgeon
~8 spots leftby Nov 2025